Medacta Group SA (0A05.L)

CHF 123.74

(-0.13%)

EBITDA Summary of Medacta Group SA

  • Medacta Group SA's latest annual EBITDA in 2023 was 119.64 Million EUR , up 13.82% from previous year.
  • Medacta Group SA's latest quarterly EBITDA in 2024 Q2 was 77.52 Million EUR , down 0.0% from previous quarter.
  • Medacta Group SA reported an annual EBITDA of 106.95 Million EUR in 2022, up 9.35% from previous year.
  • Medacta Group SA reported an annual EBITDA of 97.81 Million EUR in 2021, up 19.35% from previous year.
  • Medacta Group SA reported a quarterly EBITDA of 48.22 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Medacta Group SA reported a quarterly EBITDA of N/A for 2023 FY, up 13.82% from previous quarter.

Annual EBITDA Chart of Medacta Group SA (2023 - 2016)

Historical Annual EBITDA of Medacta Group SA (2023 - 2016)

Year EBITDA EBITDA Growth
2023 119.64 Million EUR 13.82%
2022 106.95 Million EUR 9.35%
2021 97.81 Million EUR 19.35%
2020 81.95 Million EUR 23.25%
2019 66.49 Million EUR -22.26%
2018 84.97 Million EUR 19.52%
2017 71.42 Million EUR 3.37%
2016 68.53 Million EUR 0.0%

Peer EBITDA Comparison of Medacta Group SA

Name EBITDA EBITDA Difference
Ypsomed Holding AG 161.77 Million CHF 26.043%
Metall Zug AG 23.84 Million CHF -401.82%
Ascom Holding AG 31.3 Million CHF -282.249%
COLTENE Holding AG 23.8 Million CHF -402.621%
Galenica AG 306.92 Million CHF 61.018%